Wednesday, 4 November 2015

Valeant Tells Doctors That Their Prescriptions Won’t Be Disrupted

Valeant Pharmaceuticals sent a letter to doctors to try to reassure them after the company severed its controversial business ties with specialty pharmacy Philidor. In other marketplace news, Quest Diagnostics expands its data analytics business, AmSurg suspends acquisition talks with Team Health and Pamplona announced plans to buy MedAssets for $1.86 billion.

No comments:

Post a Comment